316 related articles for article (PubMed ID: 23175386)
1. HDAC8 substrates: Histones and beyond.
Wolfson NA; Pitcairn CA; Fierke CA
Biopolymers; 2013 Feb; 99(2):112-26. PubMed ID: 23175386
[TBL] [Abstract][Full Text] [Related]
2. HDAC8 substrate selectivity is determined by long- and short-range interactions leading to enhanced reactivity for full-length histone substrates compared with peptides.
Castañeda CA; Wolfson NA; Leng KR; Kuo YM; Andrews AJ; Fierke CA
J Biol Chem; 2017 Dec; 292(52):21568-21577. PubMed ID: 29109148
[TBL] [Abstract][Full Text] [Related]
3. Substrate binding to histone deacetylases as shown by the crystal structure of the HDAC8-substrate complex.
Vannini A; Volpari C; Gallinari P; Jones P; Mattu M; Carfí A; De Francesco R; Steinkühler C; Di Marco S
EMBO Rep; 2007 Sep; 8(9):879-84. PubMed ID: 17721440
[TBL] [Abstract][Full Text] [Related]
4. Structural snapshots of human HDAC8 provide insights into the class I histone deacetylases.
Somoza JR; Skene RJ; Katz BA; Mol C; Ho JD; Jennings AJ; Luong C; Arvai A; Buggy JJ; Chi E; Tang J; Sang BC; Verner E; Wynands R; Leahy EM; Dougan DR; Snell G; Navre M; Knuth MW; Swanson RV; McRee DE; Tari LW
Structure; 2004 Jul; 12(7):1325-34. PubMed ID: 15242608
[TBL] [Abstract][Full Text] [Related]
5. Crystal structure of a eukaryotic zinc-dependent histone deacetylase, human HDAC8, complexed with a hydroxamic acid inhibitor.
Vannini A; Volpari C; Filocamo G; Casavola EC; Brunetti M; Renzoni D; Chakravarty P; Paolini C; De Francesco R; Gallinari P; Steinkühler C; Di Marco S
Proc Natl Acad Sci U S A; 2004 Oct; 101(42):15064-9. PubMed ID: 15477595
[TBL] [Abstract][Full Text] [Related]
6. Structure-Based Identification of HDAC8 Non-histone Substrates.
Alam N; Zimmerman L; Wolfson NA; Joseph CG; Fierke CA; Schueler-Furman O
Structure; 2016 Mar; 24(3):458-68. PubMed ID: 26933971
[TBL] [Abstract][Full Text] [Related]
7. Structure of 'linkerless' hydroxamic acid inhibitor-HDAC8 complex confirms the formation of an isoform-specific subpocket.
Tabackman AA; Frankson R; Marsan ES; Perry K; Cole KE
J Struct Biol; 2016 Sep; 195(3):373-378. PubMed ID: 27374062
[TBL] [Abstract][Full Text] [Related]
8. Members of the histone deacetylase superfamily differ in substrate specificity towards small synthetic substrates.
Riester D; Wegener D; Hildmann C; Schwienhorst A
Biochem Biophys Res Commun; 2004 Nov; 324(3):1116-23. PubMed ID: 15485670
[TBL] [Abstract][Full Text] [Related]
9. HDAC8 Catalyzes the Hydrolysis of Long Chain Fatty Acyl Lysine.
Aramsangtienchai P; Spiegelman NA; He B; Miller SP; Dai L; Zhao Y; Lin H
ACS Chem Biol; 2016 Oct; 11(10):2685-2692. PubMed ID: 27459069
[TBL] [Abstract][Full Text] [Related]
10. Phosphorylation of Histone Deacetylase 8: Structural and Mechanistic Analysis of the Phosphomimetic S39E Mutant.
Welker Leng KR; Castañeda CA; Decroos C; Islam B; Haider SM; Christianson DW; Fierke CA
Biochemistry; 2019 Nov; 58(45):4480-4493. PubMed ID: 31633931
[TBL] [Abstract][Full Text] [Related]
11. HDAC8: a multifaceted target for therapeutic interventions.
Chakrabarti A; Oehme I; Witt O; Oliveira G; Sippl W; Romier C; Pierce RJ; Jung M
Trends Pharmacol Sci; 2015 Jul; 36(7):481-92. PubMed ID: 26013035
[TBL] [Abstract][Full Text] [Related]
12. Design and evaluation of 'Linkerless' hydroxamic acids as selective HDAC8 inhibitors.
Krennhrubec K; Marshall BL; Hedglin M; Verdin E; Ulrich SM
Bioorg Med Chem Lett; 2007 May; 17(10):2874-8. PubMed ID: 17346959
[TBL] [Abstract][Full Text] [Related]
13. The activity of HDAC8 depends on local and distal sequences of its peptide substrates.
Gurard-Levin ZA; Mrksich M
Biochemistry; 2008 Jun; 47(23):6242-50. PubMed ID: 18470998
[TBL] [Abstract][Full Text] [Related]
14. Novel structural insights into class I and II histone deacetylases.
Ficner R
Curr Top Med Chem; 2009; 9(3):235-40. PubMed ID: 19355988
[TBL] [Abstract][Full Text] [Related]
15. Negative regulation of histone deacetylase 8 activity by cyclic AMP-dependent protein kinase A.
Lee H; Rezai-Zadeh N; Seto E
Mol Cell Biol; 2004 Jan; 24(2):765-73. PubMed ID: 14701748
[TBL] [Abstract][Full Text] [Related]
16. Structural studies of human histone deacetylase 8 and its site-specific variants complexed with substrate and inhibitors.
Dowling DP; Gantt SL; Gattis SG; Fierke CA; Christianson DW
Biochemistry; 2008 Dec; 47(51):13554-63. PubMed ID: 19053282
[TBL] [Abstract][Full Text] [Related]
17. Characterization of Histone Deacetylase 8 (HDAC8) Selective Inhibition Reveals Specific Active Site Structural and Functional Determinants.
Marek M; Shaik TB; Heimburg T; Chakrabarti A; Lancelot J; Ramos-Morales E; Da Veiga C; Kalinin D; Melesina J; Robaa D; Schmidtkunz K; Suzuki T; Holl R; Ennifar E; Pierce RJ; Jung M; Sippl W; Romier C
J Med Chem; 2018 Nov; 61(22):10000-10016. PubMed ID: 30347148
[TBL] [Abstract][Full Text] [Related]
18. Toward selective histone deacetylase inhibitor design: homology modeling, docking studies, and molecular dynamics simulations of human class I histone deacetylases.
Wang DF; Helquist P; Wiech NL; Wiest O
J Med Chem; 2005 Nov; 48(22):6936-47. PubMed ID: 16250652
[TBL] [Abstract][Full Text] [Related]
19. Histone Deacetylase 8: Characterization of Physiological Divalent Metal Catalysis.
Nechay MR; Gallup NM; Morgenstern A; Smith QA; Eberhart ME; Alexandrova AN
J Phys Chem B; 2016 Jul; 120(26):5884-95. PubMed ID: 26996235
[TBL] [Abstract][Full Text] [Related]
20. Docking of hydroxamic acids into HDAC1 and HDAC8: a rationalization of activity trends and selectivities.
Ortore G; Di Colo F; Martinelli A
J Chem Inf Model; 2009 Dec; 49(12):2774-85. PubMed ID: 19947584
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]